Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Isotope & Radiation Corp. ( (HK:1763) ) has provided an update.
China Isotope & Radiation Corporation announced a proposed gratuitous transfer of shares by its controlling shareholder, China Baoyuan Investment Co., Ltd., to its ultimate controlling shareholder, China National Nuclear Corporation (CNNC). This transfer, involving approximately 33.79% of the company’s total issued share capital, aims to enhance the company’s position and competitiveness in the nuclear technology application industry. The transfer is expected to bolster the company’s technological innovation and market expansion efforts, although it remains at a preliminary stage and may not materialize. CNNC’s increased direct stake is anticipated to strengthen the company’s influence and responsibilities within the industry.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation operates in the nuclear technology industry, focusing on the application of nuclear technology. The company is involved in technological innovation and market expansion, leveraging the brand influence and industry background of its ultimate controlling shareholder, China National Nuclear Corporation (CNNC).
Average Trading Volume: 536,136
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.31B
See more data about 1763 stock on TipRanks’ Stock Analysis page.